Trials / Sponsors / Hillhurst Biopharmaceuticals, Inc.
Hillhurst Biopharmaceuticals, Inc.
Industry · 3 registered clinical trials — 2 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Not Yet Recruiting | Low-dose Carbon Monoxide (HBI-002) Trial to Evaluate Safety, Tolerability, PK, and Biomarkers in Parkinson's D Parkinson Disease | Phase 2 | 2026-02-28 |
| Recruiting | A Safety, Efficacy, and Pharmacokinetic (PK) Study of HBI-002, an Oral Carbon Monoxide (CO) Therapeutic, in Su Anemia, Sickle Cell | Phase 1 / Phase 2 | 2025-02-15 |
| Completed | A Study to Assess the Safety and Pharmacokinetics of HBI-002, an Oral Carbon Monoxide Therapeutic, in Healthy Anemia, Sickle Cell | Phase 1 | 2022-07-25 |